The OMOP-IMEDS 2013 Symposium sponsored by the Reagan-Udall Foundation for the FDA, had over 200 people in attendance, including representation from FDA, academic, pharmaceutical and research organizations. If you missed this year’s symposium or want to hear it again, click below on any of the presentations and download the audio/slides. Some files may take a few seconds to download.
I'm in the audience at OMOP-watching talks as they are told-Searching through the SQL-Just to find the perfect code
Must be a signal in these data-Have no doubt deep in my mind-With the OMOP toolbox-I'll be able to find.
November 5 - 6, 2013 Symposium Materials
Symposium Agenda
Symposium Bios
Demonstration Descriptions
Poster Listing
References
2013 Symposium Slides and Audio
Day 1, November 5, 2013
The first link will download for you the slides in Adobe format. The second link will start the slides/audio presentation.
Exploring the OMOP Common Data Model; Patrick Ryan, PhD; Director, Epidemiology, Janssen Research and Development
CDM slides with audio (Includes introduction to the symposium by Paul Stang, PhD, Vice-President, Global Epidemiology, Janssen Research and Development)
Exploiting the OMOP Vocabulary Model for Analysis; Christian Reich, MD, PhD; Global Head of Informatics, AstraZeneca PLC
Vocabulary slides with audio
Implementing Study Designs in the OMOP Environment; David Madigan, PhD; Executive Vice President for Arts and Sciences and Dean of the Faculty of Arts and Sciences, Columbia University
Study Designs slides with audio
Day 2, November 6, 2013
The first link will download for you the slides in Adobe format. The second link will start the slides/audio presentation.
Desideratum for Evidence Based Epidemiology; J. Marc Overhage, MD, PhD; Chief Medical Informatics Officer, Siemens Health Services
Evidence base epidemiology slides with audio (Includes introduction to the symposium by Paul Stang, PhD, Vice-President, Global Epidemiology, Janssen Research and Development)
Replication of the OMOP Experiment in Europe; Martijn Schuemie PhD; Associate Director, Epidemiology, Janssen Research and Development
Replication of the OMOP slides with audio (Includes announcements of poster awards)
Beyond Crude Cohort Designs: Large-Scale Adjustment Approaches for Effect Estimation; Marc Suchard, MD, PhD; Professor, University of California, Los Angeles
Beyond crude cohort designs slides with audio
Impact of Combining Estimates on Performance; David Madigan, PhD; Executive Vice President for Arts and Sciences and Dean of the Faculty of Arts and Sciences, Columbia University
Impact of Combining Estimates slides with audio
OMOP's Vision of Risk Identification; Patrick Ryan, PhD; Director, Epidemiology, Janssen Research and Development
OMOP's Vision of Risk Identification slides with audio
Closing Comments; Richard Moscicki, MD; Deputy Center Director for Science Operations, Center for Drug Evaluation and Research, FDA; and Mark McClellan, MD, PhD; Senior Fellow and Director of the Health Care Innovation and Value Initiative, Brookings Institution; Board Member, Reagan-Udall Foundation for the FDA
2013 Posters
